冯维杨, 赵玺龙, 黄尤光, 李树德, 李俞锦. Hsp90抑制剂17-AAG通过EGFR,IGFR途径抑制乳腺癌细胞的增殖[J]. 云南大学学报(自然科学版), 2010, 32(1): 92-96 .
引用本文: 冯维杨, 赵玺龙, 黄尤光, 李树德, 李俞锦. Hsp90抑制剂17-AAG通过EGFR,IGFR途径抑制乳腺癌细胞的增殖[J]. 云南大学学报(自然科学版), 2010, 32(1): 92-96 .
shu
Hsp90 inhibitor,17-AAG,abrogates breast cancer cells growth through EGFR and IGFR-1 pathway[J]. Journal of Yunnan University: Natural Sciences Edition, 2010, 32(1): 92-96 .
Citation: Hsp90 inhibitor,17-AAG,abrogates breast cancer cells growth through EGFR and IGFR-1 pathway[J]. Journal of Yunnan University: Natural Sciences Edition, 2010, 32(1): 92-96 .
shu

Hsp90抑制剂17-AAG通过EGFR,IGFR途径抑制乳腺癌细胞的增殖

Hsp90 inhibitor,17-AAG,abrogates breast cancer cells growth through EGFR and IGFR-1 pathway

    摘要
  • 摘要: 17-AAG通过抑制Hsp90的功能而抑制多种肿瘤细胞的生长增殖,用不同浓度17-AAG作用于乳腺癌细胞株MDA-MB-231和BT474,用SRB法检测细胞相对存活数,计算半数抑制药物浓度IC50;并用Westernblotting检测Hsp90的"顾客"蛋白EGFR,IGFR-1以及G2/M细胞周期蛋白cdc2的表达,研究17-AAG抑制乳腺癌细胞的增殖,促进细胞凋亡的途径.结果显示,1μmol/L的17-AAG已能完全抑制MDA-MB-231和BT474细胞增殖,2种细胞的IC50分别为0.0587,0.0576μmol/L;17-AAG作用的乳腺癌细胞EGFR,IGFR-1表达明显下调,此作用呈剂量依赖性.这些研究结果表明17-AGG可显著抑制乳腺癌细胞MDA-MB-231和BT474的生长增殖,此作用与17-AGG抑制细胞生长因子受体途径有关.

     

    Abstract: 17 -(demethoxy),17-allylamino geldanamycin(17-AAG) suppresses growth in some cancers by inhibiting Heat shock protein90 (Hsp90).We examined in vitro the effects of 17-AAGmediated Hsp90 inhibition on human breast cancer cell lines,MDA-MB -231 and BT474.Cell viabilities were determined by SRBmethod to account IC50; EGFR,IGFR-1 and G2 /Mcell cycle checkpoint proteins cdc2 were examined by Western blotting to determine the pathway of the roles of 17-AAGin breast cancers.We found that MDA-MB-231 and BT474 treated with 17-AAGversus untreated controls showed decreased cell viability.Cells treated with 17-AAGalso showed a decrease in EGFR,IGFR-1.The results suggest that 17-AAGcould obviously abrogate MDA-MB-231 and BT474 cell growth and facilitate the two cell lines apoptosis through EGFRand IGFR-1 pathway.

     

    • HTML全文
    • 参考文献(0)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回